Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen enantiomers bioavailability study
NCT02182960Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 1998
- Primary completion
- Oct 1998
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain, inflammation and fever (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Total area under the plasma drug concentration-time curve from time zero to infinity at 12 hours and Maximum drug plasma concentration at 12 hours. Started Sep 1998; status: completed.
02
Drugs
ibuprofen
03
Conditions
paininflammationfever
Beyond the preview
Go deeper on NCT02182960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182960.